The ketoconazole market, valued at $106.24 million in 2022, is projected to grow at a CAGR of 3.1% through 2030, driven by rising demand for skin care drugs and increased product launches. The oral ketoconazole segment is expected to see significant growth, particularly in the APAC region, due to a busy lifestyle and a growing population. Major players include Mylan Inc., Johnson & Johnson, and Teva Pharmaceutical Industries.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
